Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
1026
CALL
DELISTED
Marathon Oil Corporation
MRO
| $8.46M | 0.02% |
549,700
| – | – |
|
1027
AngloGold Ashanti
AU
$60.9B
| $8.46M | 0.02% |
1,033,426
-263,772
| -20% | -$1.95M |
|
1028
BJ's Restaurants
BJRI
$1.43B
| $8.44M | 0.02% |
196,196
+68,170
| +53% | +$3.2M |
|
1029
Flex
FLEX
$39.4B
| $8.44M | 0.02% |
1,062,330
+788,228
| +288% | +$6.4M |
|
|
SOHU
1030
Sohu.com
SOHU
$379M
| $8.37M | 0.02% |
202,724
-123,032
| -38% | -$5.7M |
|
1031
CALL
Eli Lilly
LLY
$1.11T
| $8.37M | 0.02% |
100,000
-100,000
| -50% | -$8.44M |
|
1032
Ball Corp
BALL
$17.1B
| $8.35M | 0.02% |
268,576
+202,976
| +309% | +$6.88M |
|
|
VTAE
1033
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $8.35M | 0.02% |
758,455
-4,969
| -0.7% | -$52.8K |
|
1034
Truist Financial
TFC
$62.1B
| $8.35M | 0.02% |
234,466
+209,254
| +830% | +$8.07M |
|
|
GNRT
1035
DELISTED
Gener8 Maritime, Inc.
GNRT
| $8.35M | 0.02% |
762,151
-1,105,760
| -59% | -$14.4M |
|
1036
Kite Realty
KRG
$5.26B
| $8.32M | 0.02% |
349,581
+59,360
| +20% | +$1.48M |
|
|
OREX
1037
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $8.31M | 0.02% |
393,997
-70,533
| -15% | -$2.42M |
|
1038
SPDR Gold Trust
GLD
$155B
| $8.29M | 0.02% |
77,600
-244,380
| -76% | -$26.3M |
|
1039
Arbutus Biopharma
ABUS
$1.03B
| $8.26M | 0.02% |
1,355,839
-7,186
| -0.5% | -$63.7K |
|
1040
Post Holdings
POST
$3.73B
| $8.26M | 0.02% |
213,488
-435,053
| -67% | -$17.1M |
|
1041
Insulet
PODD
$10.1B
| $8.23M | 0.02% |
317,605
-1,085,752
| -77% | -$32.9M |
|
1042
Bath & Body Works
BBWI
$3.86B
| $8.23M | 0.02% |
112,931
-367,133
| -76% | -$25.4M |
|
1043
iShares China Large-Cap ETF
FXI
$4.24B
| $8.22M | 0.02% |
231,697
+26,361
| +13% | +$1.02M |
|
|
CHUY
1044
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $8.21M | 0.02% |
289,270
+278,753
| +2,650% | +$8.27M |
|
|
SJI
1045
DELISTED
South Jersey Industries, Inc.
SJI
| $8.2M | 0.02% |
324,701
+171,980
| +113% | +$4.2M |
|
|
SGEN
1046
DELISTED
Seagen Inc. Common Stock
SGEN
| $8.19M | 0.02% |
212,484
+181,583
| +588% | +$8.18M |
|
1047
Amphenol
APH
$192B
| $8.17M | 0.02% |
641,200
+447,320
| +231% | +$6.01M |
|
1048
CALL
Marathon Petroleum
MPC
$102B
| $8.17M | 0.02% |
176,300
| – | – |
|
|
DENN
1049
DELISTED
Denny's
DENN
| $8.17M | 0.02% |
740,431
-332,753
| -31% | -$3.88M |
|
1050
Ambev
ABEV
$45B
| $8.16M | 0.02% |
1,666,424
-430,596
| -21% | -$2.34M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.